Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis
Crossref DOI link: https://doi.org/10.1038/leu.2014.271
Published Online: 2014-12-10
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dispenzieri, A
Text and Data Mining valid from 2014-12-01
Version of Record valid from 2014-12-01
Article History
First Online: 10 December 2014
Competing interests
: AD receives research dollars for clinical trials from Millenium, Celgene, Pfizer, and Jannsen.
Free to read: This content has been made available to all.